Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
[HTML][HTML] The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)
M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba… - Journal of intensive …, 2021 - Springer
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …
Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem …
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The …
Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia
PD Tamma, KE Goodman, AD Harris… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background. Carbapenem-resistant Enterobacteriaceae (CRE) are associated with
considerable mortality. As mechanisms of carbapenem resistance are heterogeneous, it is …
considerable mortality. As mechanisms of carbapenem resistance are heterogeneous, it is …
Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials
Rationale: Optimization of β-lactam antibiotic dosing for critically ill patients is an intervention
that may improve outcomes in severe sepsis. Objectives: In this individual patient data meta …
that may improve outcomes in severe sepsis. Objectives: In this individual patient data meta …
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
HJ Morrill, JM Pogue, KS Kaye… - Open forum infectious …, 2015 - academic.oup.com
This article provides a comprehensive review of currently available treatment options for
infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance …
infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance …
[HTML][HTML] Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …
management of critically ill patients and beta-lactams are the most common antibiotic class …
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial
JM Dulhunty, JA Roberts, JS Davis… - Clinical infectious …, 2013 - academic.oup.com
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …
[HTML][HTML] Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams
J Gonçalves-Pereira, P Póvoa - Critical Care, 2011 - ccforum.biomedcentral.com
Several reports have shown marked heterogeneity of antibiotic pharmacokinetics (PK) in
patients admitted to ICUs, which might potentially affect outcomes. Therefore, the …
patients admitted to ICUs, which might potentially affect outcomes. Therefore, the …
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
Pseudomonas aeruginosa and Acinetobacter baumannii are major nosocomial pathogens
worldwide. Both are intrinsically resistant to many drugs and are able to become resistant to …
worldwide. Both are intrinsically resistant to many drugs and are able to become resistant to …